NP41

· Peking University Third Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NP41, covering 2021-09-14 to 2021-09-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Clinical Trial of NP41 for Cranial Nerve Fluorescence Imaging [Phase 1, Phase 2]